chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Hyperhidrosis, Insomnia, Myalgia, Nausea, Pyrexia
Clinical narrative: little bit dizzy; could not sleep; sweating; a little pain in the shoulder; nauseous; little bit of fever; felt a lot of burning from the injection site; loss of appetite; lots of muscle pain; a little headache; very tired; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (little bit dizzy), INSOMNIA (could not sleep), HYPERHIDROSIS (sweating), ARTHRALGIA (a little pain in the shoulder) and NAUSEA (nauseous) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (little bit dizzy), INSOMNIA (could not sleep), HYPERHIDROSIS (sweating), ARTHRALGIA (a little pain in the shoulder), NAUSEA (nauseous), PYREXIA (little bit of fever), VACCINATION SITE PAIN (felt a lot of burning from the injection site), DECREASED APPETITE (loss of appetite), MYALGIA (lots of muscle pain), HEADACHE (a little headache) and FATIGUE (very tired). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. At the time of the report, DIZZINESS (little bit dizzy), INSOMNIA (could not sleep), HYPERHIDROSIS (sweating), ARTHRALGIA (a little pain in the shoulder), NAUSEA (nauseous), PYREXIA (little bit of fever), VACCINATION SITE PAIN (felt a lot of burning from the injection site), DECREASED APPETITE (loss of appetite), MYALGIA (lots of muscle pain), HEADACHE (a little headache) and FATIGUE (very tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: little bit dizzy; could not sleep; sweating; a little pain in the shoulder; nauseous; little bit of fever; felt a lot of burning from the injection site; loss of appetite; lots of muscle pain; a little headache; very tired; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (little bit dizzy), INSOMNIA (could not sleep), HYPERHIDROSIS (sweating), ARTHRALGIA (a little pain in the shoulder) and NAUSEA (nauseous) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (little bit dizzy), INSOMNIA (could not sleep), HYPERHIDROSIS (sweating), ARTHRALGIA (a little pain in the shoulder), NAUSEA (nauseous), PYREXIA (little bit of fever), VACCINATION SITE PAIN (felt a lot of burning from the injection site), DECREASED APPETITE (loss of appetite), MYALGIA (lots of muscle pain), HEADACHE (a little headache) and FATIGUE (very tired). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. At the time of the report, DIZZINESS (little bit dizzy), INSOMNIA (could not sleep), HYPERHIDROSIS (sweating), ARTHRALGIA (a little pain in the shoulder), NAUSEA (nauseous), PYREXIA (little bit of fever), VACCINATION SITE PAIN (felt a lot of burning from the injection site), DECREASED APPETITE (loss of appetite), MYALGIA (lots of muscle pain), HEADACHE (a little headache) and FATIGUE (very tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: on the lower part of the arm pit,there was like a swollen ball.; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (on the lower part of the arm pit,there was like a swollen ball.) in a 34-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (on the lower part of the arm pit,there was like a swollen ball.). At the time of the report, LYMPHADENOPATHY (on the lower part of the arm pit,there was like a swollen ball.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided  No treatment medication was provided
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Off label use
Clinical narrative: This spontaneous case reported by a nurse, describes the occurrence of off label use (second dose administered on day 21) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 006C21A) for COVID-19 immunization. No medical history reported. On May 11, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Jun 1, 2021, received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Jun 1, 2021, patient experienced off label use (second dose administered on day 21). On Jun 1, 2021, off label use (second dose administered on day 21) resolved. The reporter did not provide any causality assessments, concomitant medication  or treatment information. Action taken with mRNA-1273 in response to the events: not applicable.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Fatigue, Headache, Hypoaesthesia, Malaise
Clinical narrative: shock pains in back and neck that lasted for months; numbness in lower legs; headache; fatigue; felt ill; shock pains in back and neck that lasted for months; tngling and numbness in lower legs; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MALAISE (felt ill), BACK PAIN (shock pains in back and neck that lasted for months), PARAESTHESIA (tngling and numbness in lower legs), NECK PAIN (shock pains in back and neck that lasted for months) and HYPOAESTHESIA (numbness in lower legs) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. didnt know) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 31-Dec-2020, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Dec-2020, the patient experienced MALAISE (felt ill), BACK PAIN (shock pains in back and neck that lasted for months), PARAESTHESIA (tngling and numbness in lower legs), HEADACHE (headache) and FATIGUE (fatigue). On an unknown date, the patient experienced NECK PAIN (shock pains in back and neck that lasted for months) and HYPOAESTHESIA (numbness in lower legs). At the time of the report, MALAISE (felt ill), BACK PAIN (shock pains in back and neck that lasted for months), PARAESTHESIA (tngling and numbness in lower legs), NECK PAIN (shock pains in back and neck that lasted for months), HYPOAESTHESIA (numbness in lower legs), HEADACHE (headache) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were reported. Doctor offered to take gabapentine for the tingling and numbness
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, Paraesthesia
Clinical narrative: shock pains in back and neck that lasted for months; numbness in lower legs; headache; fatigue; felt ill; shock pains in back and neck that lasted for months; tngling and numbness in lower legs; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MALAISE (felt ill), BACK PAIN (shock pains in back and neck that lasted for months), PARAESTHESIA (tngling and numbness in lower legs), NECK PAIN (shock pains in back and neck that lasted for months) and HYPOAESTHESIA (numbness in lower legs) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. didnt know) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 31-Dec-2020, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Dec-2020, the patient experienced MALAISE (felt ill), BACK PAIN (shock pains in back and neck that lasted for months), PARAESTHESIA (tngling and numbness in lower legs), HEADACHE (headache) and FATIGUE (fatigue). On an unknown date, the patient experienced NECK PAIN (shock pains in back and neck that lasted for months) and HYPOAESTHESIA (numbness in lower legs). At the time of the report, MALAISE (felt ill), BACK PAIN (shock pains in back and neck that lasted for months), PARAESTHESIA (tngling and numbness in lower legs), NECK PAIN (shock pains in back and neck that lasted for months), HYPOAESTHESIA (numbness in lower legs), HEADACHE (headache) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were reported. Doctor offered to take gabapentine for the tingling and numbness
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Peripheral coldness, Pyrexia
Clinical narrative: Arm got really cold; Fever; Chills; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL COLDNESS (Arm got really cold), PYREXIA (Fever), CHILLS (Chills) and HEADACHE (Headache) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-May-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL COLDNESS (Arm got really cold), PYREXIA (Fever), CHILLS (Chills) and HEADACHE (Headache). At the time of the report, PERIPHERAL COLDNESS (Arm got really cold), PYREXIA (Fever), CHILLS (Chills) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product information was not provided. Treatment information was not provided.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Decreased appetite, Flushing, Headache, Malaise
Clinical narrative: Flush; Feels weak/just sitting  there; Not hungry; Not well; Has headache; Has nausea; This spontaneous case was reported by a consumer and describes the occurrence of FLUSHING (Flush), ASTHENIA (Feels weak/just sitting  there), DECREASED APPETITE (Not hungry), MALAISE (Not well) and HEADACHE (Has headache) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included NAPROXEN for an unknown indication.   On 01-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Jun-2021, the patient experienced FLUSHING (Flush), ASTHENIA (Feels weak/just sitting  there), DECREASED APPETITE (Not hungry), MALAISE (Not well), HEADACHE (Has headache) and NAUSEA (Has nausea). The patient was treated with IBUPROFEN ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, FLUSHING (Flush), ASTHENIA (Feels weak/just sitting  there), DECREASED APPETITE (Not hungry), MALAISE (Not well), HEADACHE (Has headache) and NAUSEA (Has nausea) outcome was unknown.            The patient received the first dose about 3 weeks ago.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 01-Jul-2021: Follow-up received- Reporter Declined follow-up.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: Flush; Feels weak/just sitting  there; Not hungry; Not well; Has headache; Has nausea; This spontaneous case was reported by a consumer and describes the occurrence of FLUSHING (Flush), ASTHENIA (Feels weak/just sitting  there), DECREASED APPETITE (Not hungry), MALAISE (Not well) and HEADACHE (Has headache) in a 47-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included NAPROXEN for an unknown indication.   On 01-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Jun-2021, the patient experienced FLUSHING (Flush), ASTHENIA (Feels weak/just sitting  there), DECREASED APPETITE (Not hungry), MALAISE (Not well), HEADACHE (Has headache) and NAUSEA (Has nausea). The patient was treated with IBUPROFEN ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, FLUSHING (Flush), ASTHENIA (Feels weak/just sitting  there), DECREASED APPETITE (Not hungry), MALAISE (Not well), HEADACHE (Has headache) and NAUSEA (Has nausea) outcome was unknown.            The patient received the first dose about 3 weeks ago.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 01-Jul-2021: Follow-up received- Reporter Declined follow-up.
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia, Cheilitis, Glossodynia, Joint swelling, Neck pain
Clinical narrative: Swelling of tonsils; Swelling of eyelids; Sore throat; Tiny sores on tongue; Unbearable pain on neck; Swelling of fingers, knees and ankles; Facial swelling; Tiny sores on lips; Unbearable pain on elbows, wrists; This spontaneous case was reported by a consumer and describes the occurrence of TONSILLAR HYPERTROPHY (swelling of tonsils), SWELLING OF EYELID (swelling of eyelids), OROPHARYNGEAL PAIN (sore throat), GLOSSODYNIA (tiny sores on tongue) and NECK PAIN (unbearable pain on neck) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TONSILLAR HYPERTROPHY (swelling of tonsils), SWELLING OF EYELID (swelling of eyelids), OROPHARYNGEAL PAIN (sore throat), GLOSSODYNIA (tiny sores on tongue), NECK PAIN (unbearable pain on neck), JOINT SWELLING (swelling of fingers, knees and ankles), SWELLING FACE (facial swelling), CHEILITIS (tiny sores on lips) and ARTHRALGIA (unbearable pain on elbows, wrists). At the time of the report, TONSILLAR HYPERTROPHY (swelling of tonsils), SWELLING OF EYELID (swelling of eyelids), OROPHARYNGEAL PAIN (sore throat), GLOSSODYNIA (tiny sores on tongue), NECK PAIN (unbearable pain on neck), JOINT SWELLING (swelling of fingers, knees and ankles), SWELLING FACE (facial swelling), CHEILITIS (tiny sores on lips) and ARTHRALGIA (unbearable pain on elbows, wrists) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported by reporter.  No treatment medication was reported by reporter.
Sex: U
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Swelling face, Swelling of eyelid, Tonsillar hypertrophy
Clinical narrative: Swelling of tonsils; Swelling of eyelids; Sore throat; Tiny sores on tongue; Unbearable pain on neck; Swelling of fingers, knees and ankles; Facial swelling; Tiny sores on lips; Unbearable pain on elbows, wrists; This spontaneous case was reported by a consumer and describes the occurrence of TONSILLAR HYPERTROPHY (swelling of tonsils), SWELLING OF EYELID (swelling of eyelids), OROPHARYNGEAL PAIN (sore throat), GLOSSODYNIA (tiny sores on tongue) and NECK PAIN (unbearable pain on neck) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TONSILLAR HYPERTROPHY (swelling of tonsils), SWELLING OF EYELID (swelling of eyelids), OROPHARYNGEAL PAIN (sore throat), GLOSSODYNIA (tiny sores on tongue), NECK PAIN (unbearable pain on neck), JOINT SWELLING (swelling of fingers, knees and ankles), SWELLING FACE (facial swelling), CHEILITIS (tiny sores on lips) and ARTHRALGIA (unbearable pain on elbows, wrists). At the time of the report, TONSILLAR HYPERTROPHY (swelling of tonsils), SWELLING OF EYELID (swelling of eyelids), OROPHARYNGEAL PAIN (sore throat), GLOSSODYNIA (tiny sores on tongue), NECK PAIN (unbearable pain on neck), JOINT SWELLING (swelling of fingers, knees and ankles), SWELLING FACE (facial swelling), CHEILITIS (tiny sores on lips) and ARTHRALGIA (unbearable pain on elbows, wrists) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported by reporter.  No treatment medication was reported by reporter.
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Tinnitus - continuous ringing in ears; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Tinnitus - continuous ringing in ears) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, the patient experienced TINNITUS (Tinnitus - continuous ringing in ears). At the time of the report, TINNITUS (Tinnitus - continuous ringing in ears) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   no concomitant medication was provided by the reporter no treatment information was provided by the patient
Sex: U
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (arm is a little sore) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (arm is a little sore). At the time of the report, MYALGIA (arm is a little sore) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No relevant concomitant medications were provided. No treatment information was provided.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Feeling cold, Pyrexia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (freezing to death), CHILLS (experienced chills), FATIGUE (could not get out of bed) and PYREXIA (fever/very hot) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination. No medical history was reported by the reporter. Concomitant products included ATORVASTATIN for Hyperlipidemia, LISINOPRIL for Hypertension. On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Apr-2021, the patient experienced FEELING COLD (freezing to death), CHILLS (experienced chills) and FATIGUE (could not get out of bed). On 09-Apr-2021, the patient experienced PYREXIA (fever/very hot). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, FEELING COLD (freezing to death), CHILLS (experienced chills), FATIGUE (could not get out of bed) and PYREXIA (fever/very hot) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Patient reported high PSA levels.
Sex: U
Vaccine: COVID19
Symptoms: Pain, Pruritus, Rash erythematous
Clinical narrative: Big red rash; Soreness; Itchy; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (Big red rash), PAIN (Soreness) and PRURITUS (Itchy) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH ERYTHEMATOUS (Big red rash), PAIN (Soreness) and PRURITUS (Itchy). At the time of the report, RASH ERYTHEMATOUS (Big red rash), PAIN (Soreness) and PRURITUS (Itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitants were reported.  Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: 4 doses of the Moderna vaccine given to 4 patients 34 days after vial was first refrigerated; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT STORAGE ERROR (4 doses of the Moderna vaccine given to 4 patients 34 days after vial was first refrigerated) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Jun-2021, the patient experienced PRODUCT STORAGE ERROR (4 doses of the Moderna vaccine given to 4 patients 34 days after vial was first refrigerated). At the time of the report, PRODUCT STORAGE ERROR (4 doses of the Moderna vaccine given to 4 patients 34 days after vial was first refrigerated) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient had some issues with filling out AE forms No treatment medications were provided by the reporter No concomitant products were reported by the reporter   Most recent FOLLOW-UP information incorporated above includes: On 02-Jun-2021: Follow-up information received on 02-JUN-2021 contains non-significant information.
Sex: U
Vaccine: COVID19
Symptoms: Influenza like illness
Clinical narrative: Flu like symptoms; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were provided. No treatment information was provided.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Influenza like illness
Clinical narrative: Flu-like symptoms; Headache; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu-like symptoms) and HEADACHE (Headache) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like symptoms) and HEADACHE (Headache). At the time of the report, INFLUENZA LIKE ILLNESS (Flu-like symptoms) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were provided. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: her reaction was worse than mine and lasted several weeks; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (her reaction was worse than mine and lasted several weeks) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (her reaction was worse than mine and lasted several weeks). At the time of the report, VACCINATION COMPLICATION (her reaction was worse than mine and lasted several weeks) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. No treatment details were provided.   Reporter did not allow further contact
Age: 54.0
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Missing second shot; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missing second shot) in a 54-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missing second shot). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Missing second shot) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were reported.
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Headache, Influenza like illness, Pyrexia
Clinical narrative: Severe headache; Fever 103.2-103.9; Flu like symptoms; Ongoing fatigue; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Severe headache), PYREXIA (Fever 103.2-103.9), INFLUENZA LIKE ILLNESS (Flu like symptoms) and FATIGUE (Ongoing fatigue) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Severe headache), PYREXIA (Fever 103.2-103.9), INFLUENZA LIKE ILLNESS (Flu like symptoms) and FATIGUE (Ongoing fatigue). At the time of the report, HEADACHE (Severe headache), PYREXIA (Fever 103.2-103.9), INFLUENZA LIKE ILLNESS (Flu like symptoms) and FATIGUE (Ongoing fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Pyrexia: 103.2 (Inconclusive) 103.2.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       there is no lab data provided by the reportewr   Reporter did not allow further contact
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Heart rate, Pharyngeal swelling, Swelling face
Clinical narrative: Difficulty breathing; Swelling of face and throat; Swelling of face and throat; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Difficulty breathing), SWELLING FACE (Swelling of face and throat) and PHARYNGEAL SWELLING (Swelling of face and throat) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027821A or 027821B and 021C21A) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Apr-2021, the patient experienced DYSPNOEA (Difficulty breathing), SWELLING FACE (Swelling of face and throat) and PHARYNGEAL SWELLING (Swelling of face and throat). At the time of the report, DYSPNOEA (Difficulty breathing), SWELLING FACE (Swelling of face and throat) and PHARYNGEAL SWELLING (Swelling of face and throat) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Apr-2021, Heart rate: fast (High) fast heartbeat.         Concomitant products included Blood Pressure medicines. No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Headache, Nausea, Rash macular
Clinical narrative: tiny red spots on my skin too/like pin pricks with bits of blood; nausea; Continous headache; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (tiny red spots on my skin too/like pin pricks with bits of blood), NAUSEA (nausea) and HEADACHE (Continous headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH MACULAR (tiny red spots on my skin too/like pin pricks with bits of blood), NAUSEA (nausea) and HEADACHE (Continous headache). At the time of the report, RASH MACULAR (tiny red spots on my skin too/like pin pricks with bits of blood), NAUSEA (nausea) and HEADACHE (Continous headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Hives; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced URTICARIA (Hives). At the time of the report, URTICARIA (Hives) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: still be running a fever after 3 days/My fever is 103; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (still be running a fever after 3 days/My fever is 103) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (still be running a fever after 3 days/My fever is 103). At the time of the report, PYREXIA (still be running a fever after 3 days/My fever is 103) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were provided. No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Pharmacist ended up using 10 pre-drawn syringes that were drawn from a vial that was not; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT STORAGE ERROR (Pharmacist ended up using 10 pre-drawn syringes that were drawn from a vial that was not) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Pharmacist ended up using 10 pre-drawn syringes that were drawn from a vial that was not). At the time of the report, PRODUCT STORAGE ERROR (Pharmacist ended up using 10 pre-drawn syringes that were drawn from a vial that was not) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitants included. No Treatment mentioned.
Sex: M
Vaccine: COVID19
Symptoms: Gait disturbance, Myalgia
Clinical narrative: moving like an old person now; muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (moving like an old person now) and MYALGIA (muscle pain) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included DVT, Chronic pain and Spinal cord neoplasm (sand spinal cancer). Concurrent medical conditions included Atrial fibrillation. Concomitant products included AMIODARONE, GABAPENTIN, METOPROLOL TARTRATE (METOPROLIN), RIVAROXABAN (XARELTO), MORNIFLUMATE (FLOMAX [MORNIFLUMATE]), ASCORBIC ACID, ERGOCALCIFEROL, NICOTINAMIDE, RETINOL, RIBOFLAVIN, THIAMINE HYDROCHLORIDE (VITAMINS [ASCORBIC ACID;ERGOCALCIFEROL;NICOTINAMIDE;RETINOL;RIBOFLAVIN;THIAMINE HYDROCHLORIDE]) and CANNABIDIOL (CBD OIL) for an unknown indication.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced GAIT DISTURBANCE (moving like an old person now) and MYALGIA (muscle pain). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, GAIT DISTURBANCE (moving like an old person now) and MYALGIA (muscle pain) outcome was unknown.            The patient lab test includes EKG, blood work, and chest x-ray.   This case was linked to MOD-2021-194873, MOD-2021-194873 (Patient Link).   Reporter did not allow further contact
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Hypersensitivity, Malaise, Pruritus, Rash
Clinical narrative: Allergies; Itching on both legs, from calves downwards; Redness on both legs, from calves downwards; Rash on both legs, from calves downwards; Feeling unwell; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Feeling unwell), HYPERSENSITIVITY (Allergies), PRURITUS (Itching on both legs, from calves downwards), ERYTHEMA (Redness on both legs, from calves downwards) and RASH (Rash on both legs, from calves downwards) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022C21A and 014C21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LISINOPRIL for an unknown indication.   On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-May-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced MALAISE (Feeling unwell). On 22-May-2021, the patient experienced HYPERSENSITIVITY (Allergies). 22-May-2021, the patient experienced PRURITUS (Itching on both legs, from calves downwards), ERYTHEMA (Redness on both legs, from calves downwards) and RASH (Rash on both legs, from calves downwards). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 1 dosage form. At the time of the report, MALAISE (Feeling unwell), HYPERSENSITIVITY (Allergies), PRURITUS (Itching on both legs, from calves downwards), ERYTHEMA (Redness on both legs, from calves downwards) and RASH (Rash on both legs, from calves downwards) outcome was unknown.            Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram, Diarrhoea, Ultrasound abdomen, X-ray
Clinical narrative: light diarrhea for 8 weeks; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (light diarrhea for 8 weeks) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006B21A and 043B21A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included COLECALCIFEROL (VITAMIN D3) and MELATONIN for an unknown indication.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Apr-2021, the patient experienced DIARRHOEA (light diarrhea for 8 weeks). The patient was treated with BIFIDOBACTERIUM INFANTIS (ALIGN) at a dose of 1 dosage form; LACTOBACILLUS RHAMNOSUS (CULTURELLE DIGESTIVE DAILY PROBIOTIC CHEWABLES) at a dose of 1 dosage form and VITAMIN C [ASCORBIC ACID] at a dose of 1 dosage form. At the time of the report, DIARRHOEA (light diarrhea for 8 weeks) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Computerised tomogram: unknown (Inconclusive) unknown. On an unknown date, Ultrasound abdomen: unknown (Inconclusive) unknown. On an unknown date, X-ray: unknown (Inconclusive) unknown.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Align Culturelle with vitamin C is used as treatment
Sex: U
Vaccine: COVID19
Symptoms: Anxiety, Dysarthria, Nervousness, SARS-CoV-2 test
Clinical narrative: Feeling anxious or nervous; Feeling anxious or nervous; Sometimes hard to speak; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (Feeling anxious or nervous), NERVOUSNESS (Feeling anxious or nervous) and DYSARTHRIA (Sometimes hard to speak) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ANXIETY (Feeling anxious or nervous), NERVOUSNESS (Feeling anxious or nervous) and DYSARTHRIA (Sometimes hard to speak). At the time of the report, ANXIETY (Feeling anxious or nervous), NERVOUSNESS (Feeling anxious or nervous) and DYSARTHRIA (Sometimes hard to speak) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Positive after Vaccination.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant Medication reported by reporter.  No Treatment Medication reported by reporter.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Body temperature, Peripheral swelling
Clinical narrative: aches in shoulder/back; Swelling size of an orange on arm; Aches in shoulder; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (aches in shoulder/back), PERIPHERAL SWELLING (Swelling size of an orange on arm) and ARTHRALGIA (Aches in shoulder) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048B21A) for COVID-19 vaccination.     Concurrent medical conditions included Diverticulitis.   On 27-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-May-2021, the patient experienced BACK PAIN (aches in shoulder/back), PERIPHERAL SWELLING (Swelling size of an orange on arm) and ARTHRALGIA (Aches in shoulder). At the time of the report, BACK PAIN (aches in shoulder/back), PERIPHERAL SWELLING (Swelling size of an orange on arm) and ARTHRALGIA (Aches in shoulder) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-May-2021, Body temperature: 99 (Inconclusive) elevated temperature of 99 degrees.         No concomitant medication was reported.  No treatment was reported.    This case was linked to MOD-2021-083604 (Patient Link).   Reporter did not allow further contact
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Ultrasound abdomen, X-ray
Clinical narrative: Light diarrhea for 8 weeks; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Light diarrhea for 8 weeks) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 043B21A and 006B21A) for COVID-19 vaccination.     Concomitant products included MELATONIN for Sleep disorder therapy, COLECALCIFEROL (VITAMIN D3) for Vitamin D supplementation.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Apr-2021, the patient experienced DIARRHOEA (Light diarrhea for 8 weeks). At the time of the report, DIARRHOEA (Light diarrhea for 8 weeks) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Ultrasound abdomen: inconclusive Inconclusive. On an unknown date, X-ray: inconclusive Inconclusive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment details were provided.    This case was linked to MOD-2021-194982 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Chills, Myalgia
Clinical narrative: Chills; Muscle Pain; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) and MYALGIA (Muscle Pain) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CHILLS (Chills) and MYALGIA (Muscle Pain). At the time of the report, CHILLS (Chills) and MYALGIA (Muscle Pain) outcome was unknown.            No relevant concomitant medications were provided. No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Chills
Clinical narrative: Shivering; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Shivering) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHILLS (Shivering). At the time of the report, CHILLS (Shivering) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were provided. No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Tendon disorder
Clinical narrative: tendon problems after vaccine,After my vaccine I have been having trouble with tendon issues; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of TENDON DISORDER (tendon problems after vaccine,After my vaccine I have been having trouble with tendon issues) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TENDON DISORDER (tendon problems after vaccine,After my vaccine I have been having trouble with tendon issues). At the time of the report, TENDON DISORDER (tendon problems after vaccine,After my vaccine I have been having trouble with tendon issues) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.